sulforaphane has been researched along with tamoxifen in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, P; Kong, AN; Matwyshyn, GA; Rushmore, TH | 1 |
| Herman-Antosiewicz, A; Pawlik, A; Słomińska-Wojewódzka, M | 1 |
| Li, Y; Meeran, SM; Tollefsbol, TO | 1 |
| Kohli, K; Mangla, B; Neupane, YR; Singh, A | 1 |
| Kohli, K; Kumar, P; Mangla, B; Neupane, YR; Shafi, S; Singh, A | 1 |
5 other study(ies) available for sulforaphane and tamoxifen
| Article | Year |
|---|---|
Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.
Topics: Anticarcinogenic Agents; Blotting, Northern; Chloramphenicol O-Acetyltransferase; Dose-Response Relationship, Drug; Enzyme Induction; Gene Expression Regulation; Genes, Reporter; Glutathione Transferase; Humans; Isothiocyanates; Liver; Pyrazines; Sulfoxides; Tamoxifen; Thiocyanates; Thiones; Thiophenes; Time Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured | 1996 |
Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Brassicaceae; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Isothiocyanates; MCF-7 Cells; Perilipin-2; Receptors, Estrogen; Sulfides; Sulfoxides; Survivin; Tamoxifen; Thiocyanates | 2016 |
Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Epigenesis, Genetic; Estrogen Receptor alpha; Heterografts; Humans; Isothiocyanates; Mice; Neoplasm Transplantation; Phytochemicals; Sulfoxides; Tamoxifen; Treatment Outcome | 2017 |
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Humans; Isothiocyanates; Lipids; Male; Mice; Nanomedicine; Neoplasms; Rats; Receptors, Estrogen; Sulfoxides; Tamoxifen | 2019 |
Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane:
Topics: Administration, Oral; Animals; Drug Carriers; Drug Liberation; Isothiocyanates; Lipids; Nanostructures; Particle Size; Rats; Rats, Wistar; Sulfoxides; Tamoxifen | 2020 |